A retrospective observational cross-sectional study of intraoperative neuromuscular blocking agent choice and dosing in a US paediatric referral hospital before and after introduction of sugammadex^☆

Br J Anaesth. 2023 Oct;131(4):e117-e120. doi: 10.1016/j.bja.2023.07.013. Epub 2023 Aug 11.

Affiliations

¹ Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA. Electronic address: sydbro@med.umich.edu.
² Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA; Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
³ Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA.

PMID: 37574423
PMCID: PMC10624852 (available on 2024-10-01)
DOI: 10.1016/j.bja.2023.07.013

No abstract available

Keywords: neostigmine; neuromuscular blocking agent; reversal; sugammadex; suxamethonium.

Publication types

Observational Study
Letter

MeSH terms

Child
Cholinesterase Inhibitors
Cross-Sectional Studies
Hospitals
Humans
Neostigmine
Neuromuscular Blockade*
Neuromuscular Blocking Agents*
Retrospective Studies
Sugammadex

Substances

Sugammadex
Neuromuscular Blocking Agents
Neostigmine
Cholinesterase Inhibitors

Grants and funding

K08 HL159327/HL/NHLBI NIH HHS/United States